OUTCOME OF ADVANCED NSCLC PATIENTS WITH EGFR EXON 19 AND 21 MUTATIONS TREATED WITH ERLOTINIB (E) ALONE OR IN COMBINATION WITH CARBOPLATIN/PACLITAXEL (CP) IN CALGB 30406.

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Janne, PA; Wang, X; Socinski, MA; Crawford, J; Gu, L; Capelletti, M; Edelman, MJ; Villalona-Calero, MA; Kratzke, RA; Vokes, E; Miller, VA

Published Date

  • June 1, 2011

Published In

Volume / Issue

  • 6 / 6

Start / End Page

  • S447 - S448

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1556-1380

International Standard Serial Number (ISSN)

  • 1556-0864

Language

  • English